IiME are very pleased to announce another donation to the UK rituximab trial from FM-CFS Canada.
This is the second time that FM-CFS Canada has donated to the project and they have now filled two slots in the IiME Rituximab Matrix.
The donation was received from Dr Paul Grof of FM-CFS Canada.
In reply IiME chairman Kathleen McCall wrote -
"This is the second occasion that FM-CFS Canada has donated to the trial fund and enforces the international dimension of the trial and demonstrates how important international collaboration is for progress for ME/CFS."
"The very generous donations from FM-CFS Canada help enormously in continuing this venture and ensuring that people with ME/CFS and their families all over the world can look forward with hope for a better future."
Invest in ME thank FM-CFS Canada for this wonderful gesture.

http://www.fm-cfs.ca/index.html
Invest in ME are building a good foundation of biomedical research in UK/Europe and reinforcing the international collaborations that we have concentrated on creating since 2007.
We hope to make even more progress as we approach our tenth year as a charity. In May 2015 in London the charity will host our fifth international Biomedical Research into ME Colloquium research meeting - now again a two-day event. This will be followed by our tehnth international ME conference on 29th May.
More details of the conference and research colloquium are on our dedicated conference events micro-site at http://www.investinme.eu

Make a one-off donation via credit card or Paypal
Other Ways to Donate - click here
ukrituximabtrial.org
Further Information:
Return to IiME UK rituximab trial News page
|